- Home
- ARCT vs BOE Comparison
ARCT vs BOE Comparison
Compare ARCT & BOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- BOE
- Stock Information
- Founded
- ARCT 2013
- BOE 2005
- Country
- ARCT United States
- BOE United States
- Employees
- ARCT N/A
- BOE N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- BOE Trusts Except Educational Religious and Charitable
- Sector
- ARCT Health Care
- BOE Finance
- Exchange
- ARCT Nasdaq
- BOE Nasdaq
- Market Cap
- ARCT 602.7M
- BOE 684.5M
- IPO Year
- ARCT N/A
- BOE N/A
- Fundamental
- Price
- ARCT $20.60
- BOE $11.32
- Analyst Decision
- ARCT Strong Buy
- BOE
- Analyst Count
- ARCT 7
- BOE 0
- Target Price
- ARCT $65.00
- BOE N/A
- AVG Volume (30 Days)
- ARCT 338.5K
- BOE 166.1K
- Earning Date
- ARCT 11-12-2024
- BOE 01-01-0001
- Dividend Yield
- ARCT N/A
- BOE 7.30%
- EPS Growth
- ARCT N/A
- BOE N/A
- EPS
- ARCT N/A
- BOE N/A
- Revenue
- ARCT $163,866,000.00
- BOE N/A
- Revenue This Year
- ARCT $13.46
- BOE N/A
- Revenue Next Year
- ARCT $5.17
- BOE N/A
- P/E Ratio
- ARCT N/A
- BOE N/A
- Revenue Growth
- ARCT N/A
- BOE N/A
- 52 Week Low
- ARCT $17.52
- BOE $8.80
- 52 Week High
- ARCT $45.00
- BOE $10.48
- Technical
- Relative Strength Index (RSI)
- ARCT 42.91
- BOE 58.19
- Support Level
- ARCT $20.00
- BOE $11.27
- Resistance Level
- ARCT $21.86
- BOE $11.43
- Average True Range (ATR)
- ARCT 1.49
- BOE 0.10
- MACD
- ARCT -0.35
- BOE -0.00
- Stochastic Oscillator
- ARCT 18.04
- BOE 69.44
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
About BOE Blackrock Enhanced Global Dividend Trust of Beneficial Interest
Blackrock Enhanced Global Dividend Trust has an investment objective to provide current income and current gains, with a secondary investment objective of long-term capital appreciation. Further, it focuses on investing in a portfolio of equity securities and utilizing an option writing to seek total return performance and enhance distributions.